Brevan Howard Capital Management LP Sells 14,227 Shares of Globe Life Inc. $GL

Brevan Howard Capital Management LP cut its stake in shares of Globe Life Inc. (NYSE:GL) by 38.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,047 shares of the company’s stock after selling 14,227 shares during the quarter. Brevan Howard Capital Management LP’s holdings in Globe Life were worth $3,295,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Globe Life by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after buying an additional 607 shares during the last quarter. NewEdge Advisors LLC increased its holdings in shares of Globe Life by 368.1% during the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock worth $897,000 after buying an additional 5,352 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Globe Life by 11.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after acquiring an additional 58,163 shares during the last quarter. Empowered Funds LLC acquired a new stake in shares of Globe Life during the 1st quarter valued at $428,000. Finally, Focus Partners Wealth grew its position in Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock worth $1,127,000 after acquiring an additional 656 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO James Matthew Darden sold 18,318 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $145.10, for a total value of $2,657,941.80. Following the completion of the sale, the chief executive officer owned 51,093 shares in the company, valued at $7,413,594.30. This represents a 26.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Edward Hensley sold 712 shares of Globe Life stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $142.59, for a total transaction of $101,524.08. Following the transaction, the executive vice president directly owned 8,580 shares in the company, valued at approximately $1,223,422.20. This represents a 7.66% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 82,807 shares of company stock worth $12,041,286 over the last ninety days. Insiders own 1.97% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Evercore set a $157.00 price target on Globe Life in a report on Wednesday, February 18th. Piper Sandler reiterated an “overweight” rating and set a $167.00 target price on shares of Globe Life in a research report on Friday, November 21st. TD Cowen reissued a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Morgan Stanley restated an “overweight” rating and issued a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. Finally, Wells Fargo & Company raised their price target on shares of Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a research note on Wednesday, February 25th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and an average target price of $171.33.

Globe Life Stock Up 1.0%

Shares of NYSE:GL opened at $139.90 on Tuesday. Globe Life Inc. has a 1 year low of $109.38 and a 1 year high of $152.71. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The business’s 50-day moving average is $142.05 and its 200-day moving average is $138.99. The company has a market capitalization of $11.00 billion, a price-to-earnings ratio of 9.94 and a beta of 0.46.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This is a boost from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. Globe Life’s payout ratio is presently 7.67%.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.